May 3, 2022

JOHNSON & JOHNSON VISION APPOINTS PETER MENZIUSO AS COMPANY GROUP CHAIRMAN

Menziuso brings 30 years of deep healthcare expertise, with a focus on redefining healthy sight

JACKSONVILLE, Fla. AND SANTA ANA, Calif. – May 3, 2022 – Johnson & Johnson Vision*, a global leader in eye health and part of Johnson & Johnson MedTech**, today announced the appointment of Peter Menziuso as Company Group Chairman.

Mr. Menziuso now leads the full Johnson & Johnson Vision portfolio, which offers solutions designed to provide healthy sight for life. This includes world-leading brands such as ACUVUE® contact lenses, TECNIS® family of intraocular lenses, TearScience® LipiFlow®, and much more. Johnson & Johnson Vision generates nearly $5 billion in annual sales, employs more than 10,000 purpose-driven, high-performing individuals, and improves the lives of more than 52 million people each year.

“Peter’s breadth of experience and passion for eye health position him well to lead J&J Vision,” said Ashley McEvoy, Executive Vice President, Worldwide Chairman, Johnson & Johnson MedTech. “Peter has built a reputation as a purpose-driven, highly successful global leader, with a deep focus on innovation in service of healthcare professionals and patients.”

Throughout his 30+ year career at Johnson & Johnson, Mr. Menziuso has accelerated businesses to high growth by articulating a compelling vision and strategy, building high-performing teams, and strengthening accountability. Mr. Menziuso has spent half of his career in roles outside of the U.S. and has deep experience across the healthcare industry – spanning pharmaceutical, biotech, and medical devices in a variety of therapeutic areas.

A substantial part of Mr. Menziuso’s experience has been based in eye health. Prior to his appointment as Company Group Chairman, he was Worldwide President for the company’s Vision Care division. In this role, he has created and raised standards of eye care around the world and shaped a portfolio of meaningful solutions to deliver healthy sight for life. He also previously served as U.S. President for Vision Care, where he built a deep connection and appreciation of the eye health industry.

“We largely intuit life through sight—it’s how we learn, engage, connect. Across my career with Johnson & Johnson, what has fueled me has been the transformational effect we have on people’s lives on such a large scale—that focus continues,” said Mr. Menziuso. “As the only eye care company with health at its core as part of Johnson & Johnson, and with a heritage of innovation ‘firsts’, we have the unique opportunity to not just imagine what the future of eye health looks like, but to redefine it.“

Mr. Menziuso has also served as President, North America, Cardiovascular & Metabolism, Janssen, where he helped transform the $3+ billion business to a period of dynamic growth. His earlier roles within Johnson & Johnson include Vice President, Worldwide Marketing; Vice President, U.S. Sales and Market Development; and General Manager, Canada for LifeScan.

About Johnson & Johnson Vision
At Johnson & Johnson Vision*, part of Johnson & Johnson MedTech**, we have a bold ambition: to change the trajectory of eye health worldwide. Through our operating companies, we deliver innovation that enables eye care professionals to create better outcomes for patients throughout their lives, with products and technologies that address unmet needs including refractive error, cataracts, and dry eye. In communities with greatest need, we work in collaboration to expand access to quality eye care, and we are committed to helping people see better, connect better, live better. Visit us at jjvision.com, follow @JNJVision on Twitter, Johnson & Johnson Vision on LinkedIn, and @JNJVision on Facebook.

About Johnson & Johnson MedTech
At Johnson & Johnson MedTech**, we unleash diverse healthcare expertise, purposeful technology, and a passion for people to transform the future of medical intervention and empower everyone to live their best life possible. For more than a century, we have driven breakthrough scientific innovation to address unmet needs and reimagine health. In surgery, orthopaedics, vision, and interventional solutions, we continue to help save lives and create a future where healthcare solutions are smarter, less invasive, and more personalized.

*Johnson & Johnson Vision represents the products and services of Johnson & Johnson Surgical Vision, Inc., Johnson & Johnson Vision Care, Inc., and the affiliates of both.
**Johnson & Johnson MedTech comprises the surgery, orthopaedics, vision and interventional solutions businesses within Johnson & Johnson’s MedTech segment.